CLINICAL_TRIALS
trial_result
· 2019-11-21
Clinical Trial Update: Coasting Versus Antagonist Protocol in Patients at High Risk of OHSS [Phase 4]
Summary
Phase 4 trial comparing coasting versus antagonist protocol in patients at high risk of ovarian hyperstimulation syndrome has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: ClinAmygate | Conditions: Ovarian Hyperstimulation Syndrome | Phase 4 | Status: COMPLETED